Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Breast feeding women

Breast-feeding women 6 weeks to 6 months postpartum... [Pg.344]

Insertion and removal To be sure that the woman is not pregnant at the time of capsule placement and to ensure contraceptive efficacy during the first cycle of use, insert capsules during the first 7 days of the cycle or immediately after an abortion. Insertion is not recommended before 6 weeks postpartum in breast-feeding women. Infection If infection occurs, institute suitable treatment. If infection persists, remove the capsules. [Pg.225]

Wilson JT. Pragmatic assessment of medicines available for young children and pregnant or breast-feeding women. In Morselli PL, Garattini S, Sereni F, editors. Basic and therapeutic aspects of perinatal pharmacology. New York Raven Press 1975, p. 411-21. [Pg.201]

The interaction of SSRI agents with other drugs administered breast-feeding women warrants clinical attention. The degree to which SSRI medications are present in breast milk or in infant plasma remains poorly understood (Yoshida et ak, 1999 Burt et ah, 2001). For example, sertraline does not appear at high enough levels in breast-fed infants (n = 11) to alter their platelet serotonin levels (Epperson et ah, 2001). [Pg.278]

Ito S Drag therapy for breast feeding women. N Engl J Med 2000 343 118. [PMID 10891521]... [Pg.1270]

Pharmacokinetics Oral absorption of the drug increases when taken with food. It is extensively bound to serum albumin, and has a plasma half-life of 16 to 34 hours. Troglitazone is metabolized to several inactive metabolites, and can induce cytochrome P-450. The primary excretory route is in the feces. The drug is contraindicated in breast-feeding women. [Pg.465]

Austin MP, Mitchell PB. Use of psychotropic medications in breast-feeding women acute and prophylactic treatment. Aust NZ J Psychiatry 1998 32(6) 778-84. [Pg.178]

The transfer to milk of risperidone and its active metabolite 9-hydroxyrisperidone has been examined in two breast-feeding women and in one woman with risperidone-induced galactorrhea (209). The milkrplasma concentration ratio was under 0.5 for both compounds the calculated relative infant doses were 2.3%, 2.8%, and 4.7% of that of women s weight-adjusted doses neither compound was detected in the plasma of the two babies, who achieved their developmental milestones satisfactorily and did not have any adverse effect attributable to risperidone. The authors concluded that maternal risperidone therapy is unlikely to pose a significant hazard to the breast-fed infant in the short term, and recommended an individual benefit-harm analysis to take decisions about this issue. [Pg.348]

Special populations gives specific information about any possible renal, hepatic and cardiac impairments, and any precautions to be taken for treating the elderly, children, adolescents, and pregnant and breast-feeding women. [Pg.583]

Tetracyclines are contraindicated in patients with known hypersensitivity or intolerance to any member of the tetracycline femily. The use of tetracyclines during tooth development can cause permanent discoloration of teeth and is thus contraindicated in pregnant or breast-feeding women and in children 8 years of age or younger. [Pg.191]

Thus, the best approach is prevention. Since young children appear to be the most sensitive to methyl-mercury toxicity, children under 7 years and pregnant or breast-feeding women should limit their consumption of fish that are known to have high levels of methylmercury in their edible tissues. [Pg.1684]

This is to remind us that different patients have different needs. Some patients needs are greater, for example paediatric and geriatric patients may be special cases as would be pregnant or breast-feeding women. These factors may well influence the recommendations made by pharmacists or pharmacy technicians. [Pg.204]

All smokers trying to quit, except in the presence of special circumstances. Special consideration should be given before using pharmacotherapy with selected populations those with medical contraindications, those smoking fewer than 10 cigarettes/day, pregnant/breast-feeding women, and adolescent smokers. [Pg.1201]

Although most drugs will diffuse into breast miUc, there are very few instances where breast-feeding has to be discontinued. Health care providers should encourage breast-feeding women who need to use medications to continue breast-feeding whenever possible. Medications that require the mother to pump and discard miUc are few. [Pg.1439]

Many practitioners recommend progestin-only contraceptives for breast-feeding women because progestins provide effective contraception without diminishing the amount of breast milk produced. [Pg.1443]

A recent review by the Cochrane Library indicated that existing randomized, controlled trials are insufficient to establish an effect of hormonal contraception, if any, on milk quality and quantity. Furthermore, the review stated that current recommendations are for breast-feeding women to avoid combined OCs in the first 6 weeks postpartum and to use them with caution in the 6-month postpartum period. ... [Pg.1459]


See other pages where Breast feeding women is mentioned: [Pg.117]    [Pg.1059]    [Pg.344]    [Pg.233]    [Pg.254]    [Pg.362]    [Pg.331]    [Pg.434]    [Pg.794]    [Pg.519]    [Pg.449]    [Pg.186]    [Pg.298]    [Pg.325]    [Pg.45]    [Pg.45]    [Pg.1059]    [Pg.331]    [Pg.399]    [Pg.619]    [Pg.704]    [Pg.2424]    [Pg.64]    [Pg.1201]    [Pg.1459]    [Pg.1819]    [Pg.147]    [Pg.201]    [Pg.282]    [Pg.332]    [Pg.409]    [Pg.506]    [Pg.507]   
See also in sourсe #XX -- [ Pg.508 ]




SEARCH



Breast-feeding

© 2024 chempedia.info